Evidence map›Paper›PMID 32104044›Full record

ArticleJournal of inflammation research2020

The Association Between Sortilin and Inflammation in Patients with Coronary Heart Disease.

Wenxiu Han, Zhijie Wei, Hailiang Zhang, Chunmei Geng, Ruili Dang, Mengqi Yang, Jun Zhang, Changshui Wang, Pei Jiang

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Potential effects of probiotics on atherosclerosis.Microbiome research reports · 2025
    Review
  6. Article
  7. Article
  8. Sortilin and its potential role in cardiovascular pathology.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Review
  9. Article
  10. Article
  11. Association between Genetic Variants ofJournal of cardiovascular development and disease · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Probiotics Bring New Hope for Atherosclerosis Prevention and Treatment.Oxidative medicine and cellular longevity · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Association of theMedicina (Kaunas, Lithuania) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wenxiu HanDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272011, People's Republic of China.
Zhijie WeiDepartment of Medical Administration, Jining First People's Hospital, Jining Medical University, Jining 272011, People's Republic of China.
Hailiang ZhangDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272011, People's Republic of China.
Chunmei GengDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272011, People's Republic of China.
Ruili DangDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272011, People's Republic of China.
Mengqi YangDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272011, People's Republic of China.
Jun ZhangDepartment of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, People's Republic of China.
Changshui WangDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272011, People's Republic of China.
Pei JiangDepartment of Pharmacy, Jining First People's Hospital, Jining Medical University, Jining 272011, People's Republic of China.
Jining First People's Hospital · CNJining Medical University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeInflammation is a key contributor to coronary heart disease (CHD). Sortilin is a sorting receptor and has been identified as a critical regulator of inflammatory response. Therefore, our study aimed to determine the link between circulating sortilin levels, proinflammatory cytokine levels, and the occurrence of CHD. PATIENTS AND

methodsOur study included 227 CHD patients and 101 matched healthy individuals. Circulating serum levels of sortilin and proinflammatory cytokines, including IL-1β, IL-6 and TNF-α, were assessed by a double-antibody sandwich enzyme-linked immunosorbent assay (DAS-ELISA). Linear regression and correlation analyses were used to estimate the associations between sortilin and proinflammatory cytokines. Moreover, six single-nucleotide polymorphisms (SNPs) spanning the sortilin and SORL1 genes were genotyped.

resultsElevated levels of sortilin (P=0.027) and proinflammatory cytokines IL-1β (P=0.013), IL-6 (P=0.000) and TNF-α (P=0.010) were observed in CHD patients compared to those in healthy controls. Furthermore, sortilin levels were significantly positively correlated with IL-1β (r=0.252, P=0.0001), IL-6 (r=0.250, P=0.0001) and TNF-α (r=0.180, P=0.0064) levels. Notably, sortilin polymorphisms were revealed to be associated with the occurrence of CHD and varying sortilin levels. Subjects with the rs599839 AA risk genotype for CHD had significantly higher sortilin levels than those with the GG and GA genotypes (P=0.000); the same tendency was also observed in the levels of the proinflammatory cytokines IL-1β (P=0.003) and TNF-α (P=0.000). Similarly, GG carriers of rs464218 with increased sortilin levels were found to be at increased risk for CHD (P=0.014). The levels of IL-1β (P=0.025) and IL-6 (P=0.015) were also increased in these patients.

conclusionOur findings reveal that high sortilin levels may interact with inflammatory response to contribute to the occurrence of CHD. Considering that our clinical evidence suggests for the first time that sortilin involves in inflammatory response in CHD, the mechanistic role of sortilin in the progression of CHD deserves detailed investigation.

Indexed as

coronary heart diseaseinflammationpolymorphismSORL1sortilin

Identifiers

PMID32104044
PMCPMC7020934
OpenAlexW3004780724

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.